Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma

Ashley L. Hilchie; Andrew J. Sharon; Evan F. Haney; David W. Hoskin; Marcel B. Bally; Octavio L. Franco; Jennifer A. Corcoran; Robert E.W. Hancock

doi:10.1016/j.bbamem.2016.09.021

Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma

Ashley L. Hilchie, Andrew J. Sharon, Evan F. Haney, David W. Hoskin, Marcel B. Bally, Octavio L. Franco, Jennifer A. Corcoran, Robert E.W. Hancock

Psychology

科研成果: 期刊稿件 › 文章 › 同行评审

66 引用（Scopus）

源语言	英语
页（从-至）	3195-3204
页数	10
期刊	Biochimica et Biophysica Acta - Biomembranes
卷	1858
期	12
DOI	https://doi.org/10.1016/j.bbamem.2016.09.021
出版状态	已出版 - 12月 1 2016

!!!ASJC Scopus Subject Areas

生物物理学
生物化学
细胞生物学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1016/j.bbamem.2016.09.021

其它文件与链接

引用此

Hilchie, A. L., Sharon, A. J., Haney, E. F., Hoskin, D. W., Bally, M. B., Franco, O. L., Corcoran, J. A., & Hancock, R. E. W. (2016). Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma. Biochimica et Biophysica Acta - Biomembranes, 1858(12), 3195-3204. https://doi.org/10.1016/j.bbamem.2016.09.021

@article{7f334dba748e4c3597d532a3bdaa3b87,

title = "Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma",

keywords = "Anti-cancer peptide, Breast cancer, Broad-spectrum, Leukemia, Membrane lysis, Synergy",

author = "Hilchie, {Ashley L.} and Sharon, {Andrew J.} and Haney, {Evan F.} and Hoskin, {David W.} and Bally, {Marcel B.} and Franco, {Octavio L.} and Corcoran, {Jennifer A.} and Hancock, {Robert E.W.}",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier B.V.",

year = "2016",

month = dec,

day = "1",

doi = "10.1016/j.bbamem.2016.09.021",

language = "English",

volume = "1858",

pages = "3195--3204",

journal = "Biochimica et Biophysica Acta - Biomembranes",

issn = "0005-2736",

publisher = "Elsevier",

number = "12",

}

TY - JOUR

T1 - Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma

AU - Hilchie, Ashley L.

AU - Sharon, Andrew J.

AU - Haney, Evan F.

AU - Hoskin, David W.

AU - Bally, Marcel B.

AU - Franco, Octavio L.

AU - Corcoran, Jennifer A.

AU - Hancock, Robert E.W.

PY - 2016/12/1

Y1 - 2016/12/1

KW - Anti-cancer peptide

KW - Breast cancer

KW - Broad-spectrum

KW - Leukemia

KW - Membrane lysis

KW - Synergy

UR - http://www.scopus.com/inward/record.url?scp=84991801216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991801216&partnerID=8YFLogxK

U2 - 10.1016/j.bbamem.2016.09.021

DO - 10.1016/j.bbamem.2016.09.021

M3 - Article

C2 - 27693190

AN - SCOPUS:84991801216

SN - 0005-2736

VL - 1858

SP - 3195

EP - 3204

JO - Biochimica et Biophysica Acta - Biomembranes

JF - Biochimica et Biophysica Acta - Biomembranes

IS - 12

ER -

Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此